Insights into MMP-TIMP interactions

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 73-91

  Bode, Wolfram ^a   Fernandez Catalan, Carlos ^a   Grams, Frank ^a,d   Gomis Rüth, Franz Xaver ^a,e   Nagase, Hideaki ^b   Tschesche, Harald ^c   Maskos, Klaus ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c BIELEFELD UNIVERSITY   (Germany)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTHRITIS; CONFERENCE PAPER; DRUG DESIGN; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE; TUMOR GROWTH;

EID: 0032791921     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07675.x     Document Type: Conference Paper

References (72)

1. 1. Woessner, J.F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2155.
2. 2. Nagase, H., S.K. Das, S.K. Dey, J.L. Fowlkes, W. Huang & K. Brew. 1997. In Inhibitors of Metalloproteinases in Development and Disease. S.P. Hawkes, D.R. Edwards, and R. Khokha, Eds.) Harwood Academic Publishers. Lausanne, Switzerland.
3. 3. Johnson, L.L., R. Dyer & D.J. Hupe. 1998. Matrix metalloproteinases. Curr. Opin. Chem. Biol. 2: 466-471.
4. 4. Yong, V.W., C.A. Krekoski, P.A. Forsyth, R. Bell & D.R. Edwards. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21: 75-80.
5. 5. Beckett, R. & M. Whittaker. 1998. Matrix metalloproteinase inhibitors 1998. Exp. Opin. Ther. Patents 8: 259-282.
6. 6. Bottomley, K.M., W.H. Johnson & D.S. Walter. 1998. Matrix metalloproteinase inhibitors in arthritis. J. Enz. Inhib. 13: 79-101.
7. 7. Massova, I., L.P. Kotra, R. Fridman & S. Mobashery. 1998. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J. 12: 1075-1095.
8. 8. Rawlings, N.D. & A.J. Barrett. 1995. Evolutionary families of metallopeptidases. Meth. Enzymol. 248: 183-229.
9. 9. Sang, Q.A. & D.A. Douglas. 1996. Computational sequence analysis of matrix metalloproteinases. J. Prot. Chem. 15: 137-160.
10. 10. Murphy, G.J., G. Murphy & J.J. Reynolds. 1991. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett. 289: 4-7.
11. 11. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto & M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
12. 12. Sato, H., T. Kinoshita, T. Takino, K. Nakayama & M. Seiki. 1996. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393: 101-104.
13. 13. Pei, D. & S.J. Weiss. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271: 9135-9140.
14. 14. Murphy, G. & V. Knäuper. 1997. Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol. 15: 511-518.
15. 15. Docherty, A.J.P., A. Lyons, B.J. Smith, E.M. Wright, P.E. Stephens, T.J.R. Harris, G. Murphy & J.J. Reynolds. 1985. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid potentiating activity. Nature 318: 65-69.
16. 16. Stetler-Stevenson, W.G., H.C. Krutzsch & L.A. Liotta. 1989. Tissue inhibitor of metalloproteinase (TIMP-2). J. Biol. Chem. 264: 17374-17378.
17. 17. Apte, S.S., B.R. Olsen & G. Murphy. 1995. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270: 14313-14318.
18. 18. Greene, J., M. Wang, Y.E. Liu, L.A. Raymond, C. Rosen & Y.E. Shi. 1996. Molecular cloning and characterisation of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271: 30375-30380.
19. 19. Fernandez-Catalan, C., W. Bode, R. Huber, D. Turk, J.J. Calvete, A. Lichte, H. Tschesche & K. Maskos. 1998. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17: 5238-5248.
20. 20. Douglas, D.A., Y.E. Shi & Q.A. Sang. 1997. Computational sequence analysis of the tissue inhibitor of metalloproteinase family. J. Prot. Chem. 16: 237-255.
21. 21. Gomez, D.E., D.F. Alonso, H. Yoshiji & U.P. Thorgeirsson. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122.
22. 22. Cawston, T. 1998. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol. Med. Today 4: 130-137.
23. 23. Butler, G.S., H. Will, S.J. Atkinson & G. Murphy. 1997. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproeinases. Eur. J. Biochem. 244: 653-657.
24. 24. Will, H., S.J. Atkinson, G.S. Butler, B. Smyth & G. Murphy. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autocatalytic activation. J. Biol. Chem. 271: 17119-17123.
25. 25. Zucker, S., M. Drews, C. Conner, H.D. Foda, Y.A. DeClerck, K.E. Langley, W.F. Bahou, A.J.P. Docherty & J. Cao. 1998. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J. Biol. Chem. 273: 1216-1222.
26. 26. Murphy, G. & F. Willenbrock. 1995. Tissue inhibitors of matrix metalloendopeptidases. Meth. Enzymol. 248: 496-510.
27. 27. Strongin, A.Y., I.E. Collier, U. Bannikov, B.L. Marmer, G.A. Grant & G.I. Goldberg. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270: 5331-5338.
28. 28. Strongin, A.Y., B.L. Marmer, G.A. Grant & G.I. Goldberg. 1993. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268: 14033-14039.
29. 29. Kinoshita, T., H. Sato, T. Takino, M. Itoh, T. Akizawa & M. Seiki. 1996. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type I matrix metalloproteinase. Cancer Res. 56: 2535-2538.
30. 30. Huang, W., Q. Meng, K. Suzuki, H. Nagase & K. Brew. 1997. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases. J. Biol. Chem. 272: 22086-22091.
31. 31. Murphy, G., A. Houbrechts, M.I. Cockett, R.A. Williamson, M. O'Shea & A.J.P. Docherty. 1991. The N-terminal domain of human tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 8097-8102.
32. 32. Lovejoy, B., A. Cleasby, A.M. Hassell, K. Longley, M.A. Luther, D. Weigl, G. McGeehan, A.B. McElroy, D. Drewry, M.H. Lambert & S.R. Jordan. 1994. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263: 375-377.
33. 33. Borkakoti, N., F.K. Winkler, D.H. Williams, A. D'Arcy, M.J. Broadhurst, P.A. Brown, W.H. Johnson & E.J. Murray. 1994. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor. Nature Struct. Biol. 1: 106-110.
34. 34. Stams, T., J.C. Spurlino, D.L. Smith, R.C. Wahl, T.F. Ho, M.W. Qoronfleh, T.M. Banks & B. Rubin. 1994. Structure of human neutrophil collagenase reveals targe S1 ' specificity pocket. Nature Str. Biol. 1: 119-123.
35. 35. Bode, W., P. Reinemer, R. Huber, T. Kleine, S. Schnierer & H. Tschesche. 1994. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13: 1263-1269.
36. 36. Reinemer, P., F. Grams, R. Huber, T. Kleine, S. Schnierer, M. Pieper, H. Tschesche & W. Bode. 1994. Structural implications for the role of the N-terminus in the 'superactivation' of collagenases - a crystallographic study. FEBS Lett. 338: 227-233.
37. 37. Gooley, P.R., J.F. O'Connell, A.I. Marcy, G.C. Cuca, S.P. Salowe, B.L. Bush, J.D. Hermes, C.K. Esser, W.K. Hagmann, J.P. Springer & B.A. Johnson. 1994. NMR structure of inhibited catalytic domain of human stromelysin-1. Nature Struct. Biol. 1: 111-118.
38. 38. Lovejoy, B., A.M. Hassell, M.A. Luther, D. Weigl & S.R. Jordan. 1994. Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself. Biochemistry 33: 8207-8217.
39. 39. Spurlino, J.C., A.M. Smallwood, D.D. Carlton, T.M. Banks, K.J. Vavra, J.S. Johnson, E.R. Cook, J. Falvo, R.C. Wahl, T.A. Pulvino, J.J. Wendoloski & D.L. Smith. 1994. 1.56Å structure of mature truncated human fibroblast collagenase. Proteins Struct. Funct. Genet. 19: 98-109.
40. 40. Browner, M.F., W.W. Smith & A.L. Castelhano. 1995. Matrilysin-inhibitor complexes: common themes among metalloproteases. Biochemistry 34: 6602-6610.
41. 41. Becker, J.W., A.I. Marcy, L.L. Rokosz, M.G. Axel, J.J. Burbaum, P.M.D. Fitzgerald, P.M. Cameron, C.K. Esser, W.K. Hagmann, J.D. Hermes & J.P. Springer. 1995. Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Prot. Sci. 4: 1966-1976.
42. 42. Dhanaraj, V., Q.-Z. Ye, L.L. Johnson, D.J. Hupe, D.F. Ortwine, J.B. Dunbar, J.R. Rubin, A. Pavlovsky, C. Humblet & T.L. Blundell. 1996. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Structure 4: 375-386.
43. 43. Van Doren, S.R., A.V. Kurochkin, W. Hu, Q.Z. Ye, L.L. Johnson, D.J. Hupe & E.R. Zuiderweg. 1995. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor. Protein Sci. 4: 2487-2498.
44. 44. Wetmore, D.R. & K.D. Hardman. 1996. Roles of the propeptide and metal ions in the folding and stability of the catalytic domain of stromelysin (matrix metalloproteinase 3). Biochemistry 35: 6549-6558.
45. 45. Gomis-Rüth, F.X., K. Maskos, M. Betz, A. Bergner, R. Huber, K. Suzuki, N. Yoshida, H. Nagase, K. Brew, G.P. Bourenkov, H. Bartunik & W. Bode. 1997. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81.
46. 46. Grams, F., P. Reinemer, J.C. Powers, T. Kleine, M. Pieper, H. Tschesche, R. Huber & W. Bode. 1995. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design Eur. J. Biochem. 228: 830-841.
47. 47. Li, J.-Y., P. Brick, M.C. O'Hare, T. Skarzynski, L.F. Lloyd, V.A. Curry, I.M. Clark, H.F. Bigg, B.L. Hazleman, T.E. Cawston & D.M. Blow. 1995. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed β-propeller. Structure 3: 541-549.
48. 48. Libson, A., A. Gittis, I. Collier, B. Marmer, G. Goldberg & E.E. Lattman. 1995. Crystal structure of the hemopexin-like C-terminal domain of gelatinase A. Nature Struct. Biol. 2: 938-942.
49. 49. Gohlke, U., F.-X. Gomis-Rüth, T. Crabbe, G. Murphy, A.J.P. Docherty & W. Bode. 1996. The C-terminal (haemopen-like) domain structure of human gelatinase A (MMP2): structural implications for its function. FEBS Lett. 378: 126-130.
50. 50. Gomis-Rüth, F.X., U. Gohlke, M. Betz, V. Knäuper, G. Murphy, C. Lopez-Otin & W. Bode. 1996. The helping hand of collagenase-3 (MMP-13): 2.7Å crystal structure of its C-terminal haemopexin-like domain. J. Mol. Biol. 264: 556-566.
51. 51. Bode, W. (1995) A helping hand for collagenases: the haemopexin-like domain. Structure 3: 527-530.
52. 52. Williamson, R.A., G. Martorell, M.D. Carr, G. Murphy, A.J. Docherty, R.B. Freedman & J. Feeney. 1994. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33: 11745-11759.
53. 53. Williamson, R.A., M.D. Carr, T.A. Frenkiel, J. Feeney & R.B. Freedman. 1997. Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry 36: 13882-13889.
54. 54. Muskett, F.W., T.A. Frenkiel, J. Feeney, R.B. Freedman, M.D. Carr & R. Williamson. 1998. High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. J. Biol. Chem. 273: 21736-21743.
55. 55. Schechter, I. & A. Berger. 1967. On the size of the active site in proteases. 1. Papain. Biochem. Biophys. Res. Commun. 27: 157-162.
56. 56. Bode, W., F.-X. Gomis-Rüth & W. Stöcker. 1993. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins.' FEBS Lett. 331: 134-140.
57. 57. Stöcker, W., F. Grams, U. Baumann, P. Reinemer, F.X. Gomis-Rüth, D.B. McKay & W. Bode. 1995. The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Prot. Sci. 4: 823-840.
58. 58. Knäuper, V., G. Murphy & H. Tschesche. 1996. Activation of human neutrophil procollagenase by stromelysin 2. Eur. J. Biochem. 235: 187-191.
59. 59. Nagase, H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378: 151-160.
60. 60. Grams, F., M. Crimmin, L. Hinnes, P. Huxley, M. Pieper, H. Tschesche & W. Bode. 1995. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. Biochemistry 34: 14012-14020.
61. 61. Netzel-Arnett, S., G.B. Fields, H. Birkedal-Hansen & H.K. Van Wart. 1991. Sequence specificities of human fibroblast and neutrophil collagenase. J. Biol. Chem. 266: 6747-6755.
62. 62. Netzel-Arnett, S., Q.X. Sang, W.G.I. Moore, M. Navre, H. Birkedal-Hansen & H.E. Van Wart. 1993. Comparative sequence specificities of human 72-and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin) Biochemistry 32: 6427-6432.
63. 63. Niedzwiecki, L., J. Teahan, R.K. Harrison & R.L. Stein. 1992. Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluoremetric assays. Biochemistry 31: 12618-12623.
64. 64. Matthews, B.W. 1988. Structural basis of the action of thermolysin and related zinc peptidases. Ace. Chem. Res. 21: 333-340.
65. 65. Crabbe, T., S. Zucker, M.I. Cockett, F. Willenbrock, S. Tickle, J.P. O'Connell, J.M. Scothern, G. Murphy & A.J.P. Docherty. 1994. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1. Biochemistry 33: 6684-6690.
66. 66. Windsor, L.J., M.K. Bodden, B. Birkedal-Hansen, J.A. Engler & H. Birkedal-Hansen. 1994. Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J. Biol. Chem. 269: 26201-26207.
67. 67. Bode, W., F.X. Gomis-Rüth, R. Huber, R. Zwilling & W. Stöcker. 1992. Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. Nature 358: 164-166.
68. 68. Grams, F., V. Dive, A. Yiotakis, I. Yiallouros, S. Vassiliou, R. Zwilling, W. Bode & W. Stöcker. 1996. Structure of astacin with a transition-state analogue inhibitor. Nature Struct. Biol. 3: 671-675.
69. 69. Baumann, U., M. Bauer, S. Letoffe, P. Delepelaire & C. Wandersman. 1995. Crystal Structure of a complex between Serratia marcescens metallo-protease and an inhibitor from Erwinia chrysanthemi. J. Mol. Biol. 248: 653-661.
70. 70. Cao, J., H. Sato, T. Takino & M. Seiki. 1995. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for progelatinase A activation. J. Biol. Chem. 270: 801-805.
71. 71. Butler, G.S., M.J. Butler, S.J. Atkinson, H. Will, T. Tamura, S.S. Van Westrum, T. Crabbe, J. Clements, M.P. D'Ortho & G. Murphy. 1998. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. J. Biol. Chem. 273, 871-880.
72. 72. Evans, S.V. 1993. SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11: 134-138.